Protect LTC from unintended consequences of drug pricing reform
McKnight’s LTC News
As Congress and the Trump Administration advance sweeping prescription drug price reforms, it is essential to recognize independent long-term care pharmacies…Read More.
PBMs, under fire from the Trump administration, spend a record sum on lobbying
Lobbying disclosures filed on Monday revealed a flurry of pharmaceutical industry activity, including the largest-ever expenditure for the trade group representing pharmacy benefit managers….Read More.
Ohio AG Calls For ‘Immediate Legislative Action’ Against PBMs
Inside Health Policy
Ohio Attorney General Dave Yost (R) on Monday (April 22) called for the Ohio legislature to enact four policies targeting spread pricing practices by pharmacy benefit managers…Read More.
PBMs Want To Distribute New Rebate Payments; Pharmacists Disagree
Inside Health Policy
The Trump administration’s point-of-sale rebate proposal would drastically alter the way rebates are delivered, and pharmacy benefit managers are angling for responsibility to distribute the rebates under the new model…Read More.
Lawmakers ask the Trump administration to investigate PBM pricing practices
As pharmacy benefit managers undergo increasing scrutiny, two lawmakers have asked the Health and Human Services inspector general to investigate…Read More.
National LTC Pharmacy Advocacy Group Praises Grassley, Wyden Call for PBM “Spread Pricing” Probe
Cites Ohio Attorney General Yost’s Effort to Recoup Public Dollars from PBM Medicaid Managed Care Abuse…Read More.
Can Someone Tell Me What A PBM Does?
Kaiser Health News
It was back-to-school day at the Senate Finance Committee hearing Tuesday morning…Read More.
Unchecked Health Care Mergers Threaten Seniors’ Access to Prescription Drugs
Pharmacy benefit managers are the latest industry group set to appear before the Senate Finance Committee to detail their role in the drug pricing supply chain and offer ideas to lower prescription drug prices…Read More.
PBMs sidestep the Senate’s tough questions — but lawmakers hint at legislation
The much-maligned pharmacy middlemen escaped largely unscathed during a high-profile congressional hearing Tuesday — but the powerful bipartisan duo behind the hearing now appears…Read More.